0001140361-15-025028.txt : 20150622 0001140361-15-025028.hdr.sgml : 20150622 20150622152704 ACCESSION NUMBER: 0001140361-15-025028 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150622 DATE AS OF CHANGE: 20150622 EFFECTIVENESS DATE: 20150622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-242249 FILM NUMBER: 15944624 BUSINESS ADDRESS: STREET 1: 300 UTAH AVENUE STREET 2: SUITE 105 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-463-4052 MAIL ADDRESS: STREET 1: 300 UTAH AVENUE STREET 2: SUITE 105 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001645666 Kezar Life Sciences, Inc. 300 UTAH AVENUE SUITE 105 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-463-4052 DELAWARE None None Corporation true 2015 John F. Fowler 300 Utah Avenue Suite 105 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Christopher J. Kirk 300 Utah Avenue Suite 105 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Dr. Jean-Pierre Sommadossi 300 Utah Avenue Suite 105 South San Francisco CA CALIFORNIA 94080 Director Dr. Gerald Chan 300 Utah Avenue Suite 105 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2015-06-11 false true false 0 28369122 28369122 0 false 49 0 0 0 false Kezar Life Sciences, Inc. /s/ John F. Fowler John F. Fowler Chief Executive Officer 2015-06-22